Tumour budding with and without admixed inflammation: two different sides of the same coin?

被引：16

作者：

Max, Nicole ^{[1
]}

Harbaum, Lars ^{[2
]}

Pollheimer, Marion J. ^{[1
]}

Lindtner, Richard A. ^{[3
]}

Kornprat, Peter ^{[4
]}

Langner, Cord ^{[1
]}

机构：

[1] Med Univ, Inst Pathol, Auenbruggerpl 25, A-8036 Graz, Austria

[2] Univ Med Ctr Hamburg Eppendorf, BMT Sect Pneumol, Dept Oncol, Haematol,BMT Sect Pneumol, Martinistr 52, D-20246 Hamburg, Germany

[3] Med Univ Innsbruck, Dept Surg, Innrain 52, A-6020 Innsbruck, Austria

[4] Med Univ, Dept Surg, Auenbruggerpl 29, A-8036 Graz, Austria

来源：

BRITISH JOURNAL OF CANCER | 2016年 / 114卷 / 04期

关键词：

colorectal cancer; tumour budding; inflammation; prognosis; survival; multivariate logistic regression; epithelial-mesenchymal transition; II COLORECTAL-CANCER; CARCINOMA; MARKER; INDEX;

D O I：

10.1038/bjc.2015.454

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Tumour budding is an adverse prognostic indicator in colorectal cancer (CRC). Marked overall peritumoural inflammation has been associated with favourable outcome and may lead to the presence of isolated cancer cells due to destruction of invading cancer cell islets. Methods: We assessed the prognostic significance of tumour budding and peritumoural inflammation in a cohort of 381 patients with CRC applying univariate and multivariate analyses. Results: Patients with high-grade budding and marked inflammation had a significantly better outcome compared with patients with high-grade budding and only mild inflammation. Outcome in these cases, however, was still worse compared with cases with low-grade budding, in which the extent of peritumoural inflammation had no further prognostic effect. Conclusions: Tumour budding proved to be a powerful prognostic variable in patients with CRC. Scattering of invading cancer cell islets by marked overall peritumoural inflammation seems to have a minor role.

引用

页码：368 / 371

页数：4

共 47 条

[1] Tumour budding with and without admixed inflammation: two different sides of the same coin?
Nicole Max
Lars Harbaum
Marion J Pollheimer
Richard A Lindtner
Peter Kornprat
Cord Langner
British Journal of Cancer, 2016, 114 : 368 - 371
[2] Hypercholesterolemia and inflammation in atherogenesis: Two sides of the same coin
Steinberg, D
MOLECULAR NUTRITION & FOOD RESEARCH, 2005, 49 (11) : 995 - 998
[3] Infection and inflammation in liver failure: Two sides of the same coin
Malik, Raza
Mookerjee, Rajeshwar P.
Jalan, Rajiv
JOURNAL OF HEPATOLOGY, 2009, 51 (03) : 426 - 429
[4] NF-kappaB: Two Sides of the Same Coin
Pires, Bruno R. B.
Silva, Rafael C. M. C.
Ferreira, Gerson M.
Abdelhay, Eliana
GENES, 2018, 9 (01):
[5] Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same Coin
Campo, Susanna
Lacquaniti, Antonio
Trombetta, Domenico
Smeriglio, Antonella
Monardo, Paolo
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
[6] Chronic inflammation and cancer; the two sides of a coin
Fernandes, Queenie
Inchakalody, Varghese Philipose
Bedhiafi, Takwa
Mestiri, Sarra
Taib, Nassiba
Uddin, Shahab
Merhi, Maysaloun
Dermime, Said
LIFE SCIENCES, 2024, 338
[7] Editorial: HFpEF and HFmrEF: Different Sides of the Same Coin?
Martinez-Selles, Manuel
Xu, Dachun
Zhang, Jian
Ong, Sang-Bing
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
[8] Endocrinology and immunology of acne: Two sides of the same coin
Zouboulis, Christos C.
EXPERIMENTAL DERMATOLOGY, 2020, 29 (09) : 840 - 859
[9] Autoimmunity and Cancer-Two Sides of the Same Coin
Sakowska, Justyna
Arcimowicz, Lukasz
Jankowiak, Martyna
Papak, Ines
Markiewicz, Aleksandra
Dziubek, Katarzyna
Kurkowiak, Malgorzata
Kote, Sachin
Kazmierczak-Siedlecka, Karolina
Polom, Karol
Marek-Trzonkowska, Natalia
Trzonkowski, Piotr
FRONTIERS IN IMMUNOLOGY, 2022, 13
[10] Autophagy in Multiple Sclerosis: Two Sides of the Same Coin
Misrielal, Chairi
Mauthe, Mario
Reggiori, Fulvio
Eggen, Bart J. L.
FRONTIERS IN CELLULAR NEUROSCIENCE, 2020, 14

← 1 2 3 4 5 →